单位:[1]Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention, China-Japan Friendship Hospital, Beijing, China[3]Tobacco Medicine and Tobacco Cessation Center, China-Japan Friendship Hospital, Beijing, China[4]National Clinical Research Center for Respiratory Diseases, Beijing, China[5]Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom[6]Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
INTRODUCTION Treatment for smoking cessation is an important part of tobacco control and has been promoted within the Chinese health service for many years. The aim of this study was to assess the current status of smoking cessation treatment provision within the Chinese health service. METHODS A nationwide survey, sponsored by the National Health and Family Planning Commission, assessed smoking cessation activities in all 31 Provincial Health and Family Planning Commissions (PHFPCs) in China. Within the 31 provinces, 366 hospitals and primary care centers running smoking cessation clinics provided details of their activities. RESULTS Findings show that all PHFPCs took steps to promote smoking cessation, such as by conducting inspections and supervising local cessation clinics. Specifically, among the 366 health institutions, 73% were based in general hospitals, with smoking cessation clinics predominantly located in respiratory departments. Furthermore, only 43% provided smoking cessation medications. CONCLUSIONS This was the first nationwide survey of smoking cessation support available to smokers in China. It provides the most comprehensive picture of the treatment arm of smoking cessation activities so far. The Chinese government has taken measures to support smoking cessation, however, further efforts are needed to address the imbalanced distribution of resources and the limited availability of medications. On-going monitoring of barriers and facilitators affecting treatment provision is needed, as well as an understanding of the importance of each hospital focusing on working priorities specific to their needs. This survey could be a reference for other countries starting to promote smoking cessation.
基金:
National Key Research and Development Program of China [2017YFC1309400]; Communication Department of NHFPC [2016-QTL-060]
第一作者单位:[1]Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention, China-Japan Friendship Hospital, Beijing, China[3]Tobacco Medicine and Tobacco Cessation Center, China-Japan Friendship Hospital, Beijing, China[4]National Clinical Research Center for Respiratory Diseases, Beijing, China
通讯作者:
通讯机构:[1]Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[2]WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention, China-Japan Friendship Hospital, Beijing, China[3]Tobacco Medicine and Tobacco Cessation Center, China-Japan Friendship Hospital, Beijing, China[4]National Clinical Research Center for Respiratory Diseases, Beijing, China[*1]China–Japan Friendship Hospital, Chaoyang District, Beijing, China
推荐引用方式(GB/T 7714):
Lin Haoxiang,Xiao Dan,Liu Zhao,et al.National survey of smoking cessation provision in China[J].TOBACCO INDUCED DISEASES.2019,17:doi:10.18332/tid/104726.
APA:
Lin, Haoxiang,Xiao, Dan,Liu, Zhao,Shi, Qiang,Hajek, Peter&Wang, Chen.(2019).National survey of smoking cessation provision in China.TOBACCO INDUCED DISEASES,17,
MLA:
Lin, Haoxiang,et al."National survey of smoking cessation provision in China".TOBACCO INDUCED DISEASES 17.(2019)